Clinical Trials Directory

Trials / Unknown

UnknownNCT05140304

Analysis of FAZ in Diabetic Retinopathy Using OCT Angiography

Quantitative and Qualitative Analysis of Foveal Avascular Zone Characteristics in Different Stages of Diabetic Retinopathy Using Optical Coherence Tomography Angiography (OCT-A)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Kareem Mohammad Ali · Academic / Other
Sex
All
Age
10 Years
Healthy volunteers
Accepted

Summary

Study and assessment of characteristic changes in foveal avascular zone during different stages of diabetic retinopathy using OCTA.

Detailed description

OCTA is superior to other retinal imaging techniques like fluorescein angiography(FA) as it does not require dye injection, Intravenous dye injection is time consuming and can have adverse side effects. Furthermore, the edges of the capillaries can become blurred due to dye leakage and imaging of the retina can only be 2D when using FA. OCTA provides both structural and functional (i.e. blood flow) information in tandem. The "corresponding" OCT b-scans can be co-registered with the simultaneous OCT angiograms so the operator is able to scroll through the OCT angiogram like a cube scan. As a result, the precise location of pathology can be viewed on the corresponding OCT b-scans. This makes OCTA a better tool when detecting the exact location of a retinal pathology. In diabetic retinopathy OCTA can show choriocapillaris abnormalities and/or retinal microvascular abnormalities such as microaneurysms, vascular remodeling adjacent to the foveal avascular zone (FAZ), enlarged FAZ, and capillary tortuosity and dilation through different stages. OCTA can show smaller vascular changes not detectable by FA.

Conditions

Interventions

TypeNameDescription
DEVICEOCT angiographyOCT angiography of foveal avascular zone in diabetic retinopathy

Timeline

Start date
2021-11-30
Primary completion
2022-10-01
Completion
2022-11-01
First posted
2021-12-01
Last updated
2021-12-01

Source: ClinicalTrials.gov record NCT05140304. Inclusion in this directory is not an endorsement.